Raloxifene causing malabsorption of levothyroxine

Archives of Internal Medicine

Volumn 163, Issue 11, 2003, Pages 1367-1370

  Siraj, Elias S ^b   Gupta, Manjula K ^b   Reddy, S Sethu K ^a  

^a LERNER RESEARCH INSTITUTE   (United States)

^b NONE

Author keywords

[No Author keywords available]

Indexed keywords

CYANOCOBALAMIN; FERROUS SULFATE; HYDROCHLOROTHIAZIDE; LEVOTHYROXINE; LEVOTHYROXINE SODIUM; MULTIVITAMIN; RALOXIFENE; SELECTIVE ESTROGEN RECEPTOR MODULATOR; SERTRALINE; THYROXINE;

AGED; ARTICLE; BLOOD SAMPLING; CASE REPORT; DOSE RESPONSE; DRUG ABSORPTION; DRUG DOSE REGIMEN; FEMALE; HUMAN; HYPOTHYROIDISM; PRIORITY JOURNAL; THYROXINE BLOOD LEVEL;

ABSORPTION; AGED; DRUG INTERACTIONS; FEMALE; HUMANS; HYPOTHYROIDISM; RALOXIFENE; SELECTIVE ESTROGEN RECEPTOR MODULATORS; THYROXINE;

EID: 0038010801     PISSN: 00039926     EISSN: None     Source Type: Journal    
DOI: 10.1001/archinte.163.11.1367     Document Type: Article

References (24)

1. Northcutt RC, Stiel JN, Hollifield JW, Stant EG. The influence of cholestyramine on thyroxine absorption. JAMA. 1969;208:1857-1861.
2. Rosenberg R. Malabsorption of thyroid hormone with cholestyramine administration. Conn Med. 1994;58:109.
3. Phillips WA, Schultz JR, Stafford WW. Effects of colestipol hydrochloride on drug absorption in the rat, I: aspirin, L-thyroxine, phenobarbital, cortisone, and sulfadiazine. J Pharm Sci. 1974;63: 1097-1101.
4. Sherman SI, Tielens ET, Ladenson PW. Sucralfate causes malabsorption of L-thyroxine. Am J Med. 1994;96:531-535.
5. Campbell NRC, Hasinoff BB, Stalts H, Rao B, Wong NCW. Ferrous sulfate reduces thyroxine efficacy in patients with hypothyroidism. Ann Intern Med. 1992;117:1010-1013.
6. Sperber AD, Liel Y. Evidence for interference with the intestinal absorption of levothyroxine sodium by aluminum hydroxide. Arch Intern Med. 1992;152:183-184.
7. Liel Y, Sperber AD, Shany S. Nonspecific intestinal adsorption of levothyroxine by aluminum hydroxide. Am J Med. 1994;97:363-365.
8. Singh N, Singh PN, Hershman JM. Effect of calcium carbonate on the absorption of levothyroxine. JAMA. 2000;283:2822-2825.
9. Bergman F, Halvorsen P, Van der Linden W. Increased excretion of thyroxine by feeding activated charcoal to Syrian hamsters. Acta Endocrinol. 1967;56:521-524.
10. Geatti O, Barkan A, Turrin D, Orsolon PG, Shapiro B. L-thyroxine malabsorption due to the injection of herbal remedies. Thyroidology. 1993;5:97-102.
11. Arafah BM. Increased need for thyroxine in women with hypothyroidism during estrogen therapy. N Engl J Med. 2001;344:1743-1749.
12. Greenstadt MA, Spencer CA, Lum SMC, Kaptein EM, Nicoloff JT. Non-isotopic method for determination of oral thyroxine absorption. In: Gueriguaian JL, Bransome ED, Outschoorn AS, eds. Hormone Drugs: Proceedings of the FDA-USP Workshop on Drug and Reference Standards for Insulins, Somatotropins, and Thyroid-Axis Hormones. Bethesda, Md: US Pharmacopoeial Convention Inc; 1982:534-539.
13. Ain KB, Refetoff S, Fein HG, Weintraub BD. Pseudomalabsorption of levothyroxine. JAMA. 1991; 266:2118-2120.
14. Tunbridge WM, Evered DC, Hall R, et al. The spectrum of thyroid disease in a community: the Whickham survey. Clin Endocrinol (Oxf). 1977;7:481-493.
15. Canaris GJ, Manowitz NR, Mayor G, Ridgway C. The Colorado thyroid disease prevalence study. Arch Intern Med. 2000;160:526-534.
16. Colditz GA, Hankinson SE, Hunter DJ, et al. The use of estrogens and progestins and the risk of breast cancer in postmenopausal women. N Engl J Med. 1995;332:1589-1593.
17. Keating N, Cleary P, Aossi A, Zaslavsky A, Ayanlan J. Use of hormone replacement therapy by postmenopausal women in the United States. Ann Intern Med. 1999;130:545-553.
18. Writing Group for the Women's Health Initiative Investigators. Risk and benefits of estrogen plus progestin in healthy postmenopausal women: principal results from the Women's Health Initiative randomized controlled trial. JAMA. 2002;288:321-333.
19. Bevans JS, Munro JF. Thyroxine malabsorption following intestinal bypass surgery. Int J Obes. 1986;10:245-246.
20. Stone E, Leiter LA, Lambert JR, Silverberg JDH, Jeejeebhoy KN, Burrow GN. L-thyroxine absorption in patients with short bowel. J Clin Endocrinol Metab. 1984;59:139-141.
21. Hays MT. Absorption of oral thyroxine in man. J Clin Endocrinol Metab. 1968;28:749-756.
22. Surks MI, Schadlow AR, Stock JM, Oppenheimer JH. Determination of iodothyronine absorption and conversion of L-thyroxine (T4) to L-triiodothyronine (T3) using turnover rate technique. J Clin Invest. 1973;52:805-811.
23. Mani LS, Desai KB, Joseph LJ, Gantara RD. Intestinal absorption of labeled triiodothyronine in man. Indian J Gastroenterol. 1985;4:239-241.
24. Hays M. Thyroid hormone and the gut. Endocr Res. 1988;14:203-224.